Per2 protein levels were found to be downregulated in proliferative prostate cancer cells compared to normal prostate cells, whereas melatonin treatment resulted in a resynchronization of oscillatory circadian rhythm genes (Dbp and Per2) [38]. The gene discussed is PER2; the disease is prostate carcinoma.